Skye Bioscience, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.9M | $68.4M | $1.3M | $1.2M | $9.0M | $2.5M | $1.8M | $1.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $27.1M | $70.8M | $11.7M | $8.9M | $9.6M | $2.7M | $2.0M | $2.0M |
| Property, Plant & Equipment | $898.9K | $1.4M | $43.3K | $87.9K | $87.7K | $7.3K | $2.0K | $3.4K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $28.3M | $72.8M | $11.9M | $9.1M | $9.9M | $2.7M | $2.0M | $2.0M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $569.3K | — | $1.7M | $897.9K | $364.3K | $129.8K | $15.6K |
| Total Current Liabilities | $8.2M | $4.3M | $13.9M | $12.1M | $3.9M | $787.2K | $970.8K | $15.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $8.3M | $4.6M | $14.1M | $12.1M | $4.0M | $2.2M | $1.4M | $17.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-186.9M | $-130.9M | $-104.4M | $-66.7M | $-47.3M | $-38.7M | $-32.2M | $-33.2M |
| Total Stockholders' Equity | $20.0M | $68.2M | $-2.1M | $-3.0M | $5.9M | $450.8K | $548.1K | $-15.6M |